IL6 and inflammatory breast carcinoma: Interactions between IBC cells and the TME lead to a variety of pathway crosstalk (such as JAK-STAT, NF-κB, IL-6, TGFβ, and EGFR pathways) that can contribute to the IBC aggressiveness [4].